dc.contributor | Departament de Salut |
dc.contributor.author | Programa d'Harmonització Farmacoterapèutica |
dc.date.accessioned | 2021-11-11T09:45:34Z |
dc.date.available | 2021-11-11T09:45:34Z |
dc.date.issued | 2021 |
dc.identifier.citation | Programa d'Harmonització Farmacoterapèutica. Tractament del carcinoma de cèl·lules renals avançat en segona línia: informe d’avaluació de resultats. Barcelona: Servei Català de la Salut; 2021. |
dc.identifier.uri | https://hdl.handle.net/11351/6526 |
dc.description | Advanced renal cell carcinoma; Tyrosine kinase inhibitors; MTOR inhibitors; Immunotherapy; Health results |
dc.description.abstract | The data reported by prescribers have been selected for patients who have been treated in the Integral Health System of Catalonia (SISCAT) with axitinib, cabozantinib (anti-VEGF), nivolumab (anti-PDL1) or everolimus (mTOR inhibitors) and were included in the CatSalut Register of Patients and Treatments (RPT) between January 2013 and April 2021. About 78% of the patients analyzed met the clinical criteria for treatment established in the harmonization agreement and the 12 months of follow-up more than 28% of treated patients had not progressed and about 45% of patients were still alive. |
dc.language.iso | cat |
dc.publisher | Servei Català de la Salut |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ |
dc.source | Scientia |
dc.subject | Ronyons - Càncer - Tractament |
dc.subject | Avaluació de resultats (Assistència sanitària) |
dc.subject.mesh | Kidney Neoplasms |
dc.subject.mesh | /drug therapy |
dc.subject.mesh | Drug Evaluation |
dc.title | Tractament del carcinoma de cèl·lules renals avançat en segona línia: informe d’avaluació de resultats |
dc.type | info:eu-repo/semantics/report |
dc.subject.decs | neoplasias renales |
dc.subject.decs | /farmacoterapia |
dc.subject.decs | evaluación de medicamentos |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |